This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northwestern University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hiroaki Kiyokawa: Innovator in Ubiquitin Ligase Inhibitors
Introduction
Hiroaki Kiyokawa is a prominent inventor based in Evanston, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of ubiquitin ligase inhibitors. His work is crucial for advancing therapeutic strategies in various diseases.
Latest Patents
Hiroaki Kiyokawa holds a patent titled "HECT E3 Ubiquitin Ligase Inhibitors and Uses Thereof." This patent represents his innovative approach to targeting specific proteins involved in cellular processes, which can have profound implications for drug development.
Career Highlights
Kiyokawa is affiliated with Northwestern University, where he conducts research and collaborates with other scientists. His academic background and research focus have positioned him as a key figure in his field.
Collaborations
He has worked alongside notable colleagues such as Rama K Mishra and Chi-Hao Luan. These collaborations enhance the scope and impact of his research, fostering a dynamic environment for innovation.
Conclusion
Hiroaki Kiyokawa's contributions to the field of ubiquitin ligase inhibitors exemplify the importance of innovative research in addressing complex biological challenges. His work continues to inspire advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile